Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation

APMIS

Volumn 107, Issue 1, 1999, Pages 111-119

  Henriet, Patrick ^a   Blavier, Laurence ^a   Declerck, Yves A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Extracellular matrix; Metalloproteinases; Tissue inhibitor of metalloproteinases; Tumor invasion

Indexed keywords

PROTEIN P27; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INVASION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GROWTH STIMULATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 0033003988     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01533.x     Document Type: Article

References (76)

1. 1. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
2. 2. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-41.
3. 3. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990;265:13933-8.
4. 4. DeClerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 1989;264:17445-53.
5. 5. Apte SS, Hayashi K, Seidin MF, Mattei MG, Hayashi M, Olsen BR. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. Dev Dyn 1994;200:177-97.
6. 6. Cawston TE, Galloway AW, Mercer E, Murphy G, Reynolds JJ. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981;195:159-65.
7. 7. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271:30375-80.
8. 8. Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA, et al. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett 1997;401:213-7.
9. 9. Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP. Human skin fibroblast collagenase: interaction with substrate and inhibitor. Collagen Rel Res 1985;5:167-79.
10. 10. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation - Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996; 271:17119-23.
11. 11. DeClerck YA, Yean TD, Lu HS, Ting J, Langley KE. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI TIMP-2. J Biol Chem 1991;266:3893-9.
12. 12. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991; 266:13064-9.
13. 13. Strongin AY, Marmer BL, Grant Ga, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993;268:14033 9.
14. 14. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG. Cellular activation of the 72 kDa type TV procollagenase/TIMP-2 complex. Kidney lnt 1993;43:163-70.
15. 15. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91.
16. 16. Goldberg GI, Marmer BL, grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 1989;86:8207-11.
17. 17. Howard EW, Banda MJ. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site. J Biol Chem 1991;266:17972-7.
18. 18. Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJ. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 1991;30: 8097-102.
19. 19. DeClerck YA, Yean TD, Lee Y, Tomich JM; Langley KE. Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J 1993;289:65-9.
20. 20. Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC. K563 cells produce and respond to human erythroid-potentiating activity. Blood 1988;71:1720-5.
21. 21. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985;316:768-71.
22. 22. Stetler-Stevenson WG, Bersch N, Golde DW Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett 1992;296:231-4.
23. 23. Nemeth JA, Rafe A, Steiner M, Goolsby CL. TIMP-2 growth-stimulatory activity: a concentration and cell type-specific response in the presence of insulin. Exp Cell Res 1996;224:110-5.
24. 24. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994;107: 2373-9.
25. 25. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992;298:29-32.
26. 26. Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 1995;270:13453-9.
27. 27. Chesler L, Golde DW, Bersch N, Johnson MD. Metalloproteinase inhibition and erythroid potentiation are independent activities of inhibitor of metalloproteinases-1. Blood 1995;86:4506-15.
28. 28. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 1991;9:543-51.
29. 29. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994;54:4805-12.
30. 30. De Clerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
31. 31. Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, et al. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 1994;54:4791-7.
32. 32. Wang X, Fu X, Brown PD, Crimmin JM, Hoffman RM. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994;54:4726-8.
33. 33. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Inhibition of organ invasion by the matrix metalloproteinase inhbitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995;55:3629-33.
34. 34. Watson SA, Morris TM, Parsons SL, Steele RJC, Brown PD. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br J Cancer 1996;74:1354-8.
35. 35. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FK. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-91.
36. 36. Talbot DC, Brown PD. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. Eur J Cancer [A] 1996;32A:2528-33.
37. 37. Brown PD. Preclinical and clinical studies on the matrix metalloproteinase inhibitor, batimastat (BB-94). Clin Experimental Metastasis 1994;12:23 (abstract).
38. 38. Vlodavsky I, Korner G, Ishai Michaeli R, Bashkin P, Bar Shavit R, Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990;9:203-26.
39. 39. Fowlkes JL, Enghild JJ, Suzuki K, Nagase H. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem 1994;269:25742-6.
40. 40. Fowlkes JL, Thrailkill KM, Serra DM, Nagase H. Insulin-like growth factor binding protein (IGFBP) substrate zymography - A new tool to identify and characterize IGFBP-degrading proteinases. Endocrine 1997;7:33-6.
41. 41. Thie M, Schlumberger W, Semich R, Rauterberg J, Robenek H. Aortic smooth muscle cells in collagen lattice culture: effects on ultrastructure, proliferation and collagen synthesis. Eur J Cell Biol 1991;55:295-304.
42. 42. Mio T, Adachi Y, Romberger DJ, Ertl RF, Rennard SI. Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim 1996;32:427-33.
43. 43. Nishiyama T, Tsunenage M, Nakayama Y, Adachi E, Hayashi T. Growth rate of human flbroblasts is repressed by the culture within reconstituted collagen matrix but not by the culture on the matrix. Matrix 1989;9:193-9.
44. 44. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996;87:1069-78.
45. 45. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996;122:1723-36.
46. 46. Blavier L, DeClerck YA. Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. Mol Biol Cell 1997;8:1513-27.
47. 47. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 1994;54:5467-73.
48. 48. Sherr CJ, Gl phase progression: cycling on cue. Cell 1994;79:551-5.
49. 49. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
50. 50. Matsushime H, Quelle DE, Shurleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994;14:2066-76.
51. 51. Tsai LH, Lees E, Faha B, Harlow E, Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 1993;8:1593-602.
52. 52. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
53. 53. Lala PK, Graham CH. Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev 1990;9:369-79.
54. 54. Canete Soler R, Gui YH, Linask KK, Muschel RJ. Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Dev Dyn 1995;204:30-40.
55. 55. DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE. Inhibition of tumor invasion of smooth muscle cell lavers by recombinant human metalloproteinase inhibitor. Cancer Res 1991;51:2151-7.
56. 56. Imren S, Kohn DB, Shimada H, Blavier L, DeClerck YA. Overexpression of tissue inhibitor of metalloproteinases-2 in vivo by retroviral mediated gene transfer inhibits tumor growth and invasion. Cancer Res 1996;56:2891-5.
57. 57. Visscher DW, Hoyhtyea M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, et al. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 1994;59:339-44.
58. 58. Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, et al. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 1996;56:1654-9.
59. 59. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, et al. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 1996;74:853-62.
60. 60. Werb Z, ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439-42.
61. 61. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991;83:775-9.
62. 62. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse R Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-I) in B 16-F10 melanoma cells. J Natl Cancer Inst 1992;84:1017-22.
63. 63. Montgomery AM, DeClerck YA, Langley KE, Reisfeld RA, Mueller BM. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent protelytic pathways. Cancer Res 1993;53:693-700.
64. 64. Persky B, Ostrowski LE, Pagast P, Ahsan A, Schultz RM. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion. Cancer Res 1986;46:4129-34.
65. 65. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990;82:589-95.
66. 66. Sledge GW Jr, Qulali M, Goulet R, Bone EA, Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995;87:1546-50.
67. 67. An ZL, Wang XE, Willmott N, Chander SK, Tickle S, Docherty AJP, et al. Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis 1997;15:184-95.
68. 68. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, Jackman J, et al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metallproteinases (TIMP)-3. Carcinogenesis 1996;17: 1805-11.
69. 69. Naito K, Kanbayashi N, Nakajima S, Murai T, Arakawa K, Nishimura S, et al. Inhibition of growth of human tumor-cells in nude-mice by a metalloproteinase inhibitor. Intl J Cancer 1994;58:730-5.
70. 70. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, Hayakawa T. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 1990;171: 1264-71.
71. 71. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157:351-8.
72. 72. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 1995;8:287-93.
73. 73. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, Dorazi G, Murphy AN, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 1993;156:235-46.
74. 74. Johnson MD, Kim HR, Chesler L, Tsao Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994; 160:194-202.
75. 75. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 1997;38:817-23.
76. 76. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, et al. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994;8:1237-44.